Literature DB >> 20833000

Update on the global spread of dengue.

Alfonso Guzman1, Raul E Istúriz.   

Abstract

The global spread of dengue fever within and beyond the usual tropical boundaries threatens a large percentage of the world's population, as human and environmental conditions for persistence and even spread are present in all continents. The disease causes great human suffering, a sizable mortality from dengue haemorrhagic fever and its complications, and major costs. This situation has worsened in the recent past and may continue to do so in the future. Efforts to decrease transmission by vector control have failed, and no effective antiviral treatment is available or foreseeable on the immediate horizon. A safe and effective vaccine protective against all serotypes of dengue viruses is sorely needed.
Copyright © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833000     DOI: 10.1016/j.ijantimicag.2010.06.018

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  71 in total

1.  Factors associated with dengue mortality in Latin America and the Caribbean, 1995-2009: an ecological study.

Authors:  Fredi Alexander Díaz-Quijano; Eliseu Alves Waldman
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 2.  Return of epidemic dengue in the United States: implications for the public health practitioner.

Authors:  Nidhi Bouri; Tara Kirk Sell; Crystal Franco; Amesh A Adalja; D A Henderson; Noreen A Hynes
Journal:  Public Health Rep       Date:  2012 May-Jun       Impact factor: 2.792

3.  Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme.

Authors:  Hillary J Stahla-Beek; Daniel G April; Bejan J Saeedi; Amanda M Hannah; Susan M Keenan; Brian J Geiss
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

4.  Mutation of Putative N-Glycosylation Sites on Dengue Virus NS4B Decreases RNA Replication.

Authors:  Nenavath Gopal Naik; Huey-Nan Wu
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

5.  Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines.

Authors:  James F Kelley; Pakieli H Kaufusi; Esther M Volper; Vivek R Nerurkar
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

6.  Weather-driven variation in dengue activity in Australia examined using a process-based modeling approach.

Authors:  Melanie Bannister-Tyrrell; Craig Williams; Scott A Ritchie; Gina Rau; Janette Lindesay; Geoff Mercer; David Harley
Journal:  Am J Trop Med Hyg       Date:  2012-11-19       Impact factor: 2.345

7.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

8.  Comparing dengue and chikungunya emergence and endemic transmission in A. aegypti and A. albopictus.

Authors:  Carrie A Manore; Kyle S Hickmann; Sen Xu; Helen J Wearing; James M Hyman
Journal:  J Theor Biol       Date:  2014-05-04       Impact factor: 2.691

9.  Maintenance of dimer conformation by the dengue virus core protein α4-α4' helix pair is critical for nucleocapsid formation and virus production.

Authors:  Pak-Guan Teoh; Zhi-Shun Huang; Wen-Li Pong; Po-Chiang Chen; Huey-Nan Wu
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Towards a Hybrid Agent-based Model for Mosquito Borne Disease.

Authors:  S M Mniszewski; C A Manore; C Bryan; S Y Del Valle; D Roberts
Journal:  Summer Comput Simul Conf (2014)       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.